Ampersand Biomedicines develops multi-specific medicines that accurately target therapeutic molecules to specific cells and biological contexts. Originating from Flagship Pioneering, the company emphasizes innovation in biotechnology, fostering a dynamic and entrepreneurial work culture. Ampersand's Pilsen Team specializes in the discovery and optimization of therapeutic antibodies, utilizing advanced technologies such as microfluidics and phage display libraries. Their mission centers on addressing complex health challenges through cutting-edge therapeutics, blending a collaborative environment with a strong focus on research and development.